← Back to Clinical Trials
Recruiting NCT07447232

NCT07447232 Comparing Ultrasonic and Conventional Spirometry in Chronic Respiratory Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07447232
Status Recruiting
Phase
Sponsor Fu Jen Catholic University
Condition Chronic Obstructive Pulmonary Disease (COPD)
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2026-06-29
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Spirometer

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2026-06-29 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study compares a handheld ultrasonic spirometer with a standard hospital spirometer in adults with chronic respiratory diseases. Each participant will complete lung function tests using both devices. The study aims to determine whether the ultrasonic device provides accurate and reliable measurements for use in clinical or home settings.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18 to 80 years. * Diagnosed with a chronic respiratory disease (e.g., COPD, asthma, bronchiectasis, or interstitial lung disease). * Willing to follow the instructions for using the ultrasonic spirometer. * Clinically stable and able to understand the study purpose and procedures, and who provide informed consent. Exclusion Criteria: * Individuals who, after explanation, are still unable to properly perform the ultrasonic spirometry procedure. * Individuals who, after explanation, refuse to participate in the study. * Patients with unstable vital signs. * Pregnant or suspected pregnant women.

Contact & Investigator

Central Contact

Ke-Yun Chao, PhD

✉ 148540@mail.fju.edu.tw

📞 +886905301879

Principal Investigator

Ke-Yun Chao, PhD

PRINCIPAL INVESTIGATOR

Fu Jen Catholic University

Frequently Asked Questions

Who can join the NCT07447232 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Chronic Obstructive Pulmonary Disease (COPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07447232 currently recruiting?

Yes, NCT07447232 is actively recruiting participants. Contact the research team at 148540@mail.fju.edu.tw for enrollment information.

Where is the NCT07447232 trial being conducted?

This trial is being conducted at New Taipei City, Taiwan.

Who is sponsoring the NCT07447232 clinical trial?

NCT07447232 is sponsored by Fu Jen Catholic University. The principal investigator is Ke-Yun Chao, PhD at Fu Jen Catholic University. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology